Long-form guides for regulated export, EU-GMP and QP expectations, GDP logistics, and EU market strategy.
EU GMP & QPWhen drying, trimming, and curing trigger EU-GMP and Annex 7 herbal rules—not agriculture alone—and how Thai post-harvest facilities should design validation, change control, and batch records for EU inspectors.
Read guide →
EU Market StrategyA practical Thai-to-EU export roadmap: licence-to-lot traceability, GACP-to-GMP transition, QP-ready records, GDP logistics, and digital systems like Cantrak—why document quality wins bids before scale alone.
Read guide →
Thailand RegulatoryHow Thailand B.E. 2568 controlled-herb rules reshape medical cannabis export: DTAM oversight, export licensing intent, permit documentation, and what EU importers expect when sourcing from Thai operators.
Read guide →
Thailand RegulatoryLow-THC medical export norms, narcotics research exceptions, batch-level DTAM reporting, and seed-to-sale traceability for Thai cannabis moving toward the European medicinal supply chain.
Read guide →
EU Market StrategyDigital seed-to-sale traceability (Cantrak) for export-grade evidence: linking licences, batch genealogy, lab COAs, and shipping paperwork so EU partners reduce spreadsheet risk and due diligence time.
Read guide →
Origin QualityTurning Thai GACP and lab data into Ph. Eur.-style specification thinking for EU medical cannabis: identity, purity, microbiological strategy, and trending that supports importer monograph discussions.
Read guide →
EU Market StrategyGermany medical cannabis demand, import pathways, EU-GMP expectations, and partnership models for Thai suppliers—strategic overview of how the largest EU market sources compliant inflorescence and extracts.
Read guide →
GDP LogisticsGDP cold-chain design for Thailand-to-Europe medical cannabis: lane qualification, temperature mapping, logger traceability to airway bills, and documentary evidence EU GDP auditors accept under stress.
Read guide →
Origin QualityThai GACP as the farm foundation for EU-bound medical cannabis: contamination control, genetics traceability, heavy metals, and why GACP maturity beats raw hectarage when negotiating with EU-GMP partners.
Read guide →
EU GMP & QPHow the European Qualified Person certifies batches for the medicinal market, what Thai exporters should pre-build in batch folders, analytical packages, and impurity narratives before QP review.
Read guide →